<html>
<head>PUBMED IDs for MYNN</head>
<body bgcolor='#C5F0F2'><h1>MYNN</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17409414/'>Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.</a> April 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/20386695/'>Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis.</a> June 17  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/24455749/'>Identifying candidate genes for Type 2 Diabetes Mellitus and obesity through gene expression profiling in multiple tissues or cells.</a> June 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24478790/'>Genome wide association and linkage analyses identified three loci-4q25, 17q23.2, and 10q11.21-associated with variation in leukocyte telomere length: the Long Life Family Study.</a> January 31  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/28108556/'>Confirmation of five novel susceptibility loci for systemic lupus erythematosus (SLE) and integrated network analysis of 82 SLE susceptibility loci.</a> January 22  2017<br></body></html>
